8-KOther EventsExhibits & Filings

TEXAS INSTRUMENTS INC 8-K Report, Corporate Update (May 23, 2025)

Filed May 23, 2025For Securities:TXN

Summary

Texas Instruments Incorporated (TXN) has announced the successful completion of a significant debt offering, raising a total of $1.2 billion. This issuance comprises $550 million in 4.500% Notes due 2030 and $650 million in 5.100% Notes due 2035. The offering was conducted under the company's effective shelf registration statement and was executed through an underwriting agreement with Barclays Capital Inc., Morgan Stanley & Co. LLC, and MUFG Securities Americas Inc. This capital raise is a standard corporate finance activity for a company of Texas Instruments' size and strategic objectives. Investors should note the interest rates and maturity dates of these new notes as they represent a new component of the company's long-term debt structure. The proceeds from this offering are not specified in this particular filing, but such debt issuances are typically used for general corporate purposes, including funding capital expenditures, acquisitions, or refinancing existing debt.

Key Highlights

  • 1Texas Instruments successfully issued $1.2 billion in new debt.
  • 2The issuance consists of two tranches: $550 million in 4.500% Notes due 2030 and $650 million in 5.100% Notes due 2035.
  • 3The debt offering was completed on May 23, 2025.
  • 4The notes were offered under the company's existing shelf registration statement filed on February 14, 2025.
  • 5Key underwriters for the offering included Barclays Capital Inc., Morgan Stanley & Co. LLC, and MUFG Securities Americas Inc.
  • 6The issuance was governed by an Indenture dated May 23, 2011, and a related Officers' Certificate.

Frequently Asked Questions

Texas Instruments issued a total of $1.2 billion in debt.

The company issued $550 million of 4.500% Notes due 2030 and $650 million of 5.100% Notes due 2035.

This filing does not specify the exact use of proceeds. Typically, debt issuances of this nature are for general corporate purposes, which can include funding operations, capital expenditures, acquisitions, or refinancing existing debt.

The underwriters for this offering were Barclays Capital Inc., Morgan Stanley & Co. LLC, and MUFG Securities Americas Inc.